Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Weibo Recovery Still In The Works Due To Soft Ad Revenue, Analyst No Longer Bullish

Published 28/03/2024, 15:20
Updated 28/03/2024, 16:40
© Reuters Weibo Recovery Still In The Works Due To Soft Ad Revenue, Analyst No Longer Bullish

Benzinga - by Priya Nigam, Benzinga Staff Writer.

When Weibo Corp (NASDAQ: WB) reported mixed fourth-quarter results, the recovery in its advertising revenues was softer than anticipated in 2023.

The company now seems headed for incremental sales and margin pressure this year, according to Goldman Sachs.

The Weibo Analyst: Timothy Zhao downgraded the rating for Weibo from Buy to Neutral, while reducing the price target from HK$133 (US$17.10) to HK$83 (US$10.60).

The Weibo Thesis: The company’s revenue recovery was impacted by weaker household consumption and stiff content competition, especially in the FMCG vertical, Zhao said in the downgraded note.

Check out other analyst stock ratings.

“We have seen continued soft revenue from beauty and personal brands, due to structural wallet share loss to SFVs,” he added.

Higher investments in vertical content, like 3C, auto, gaming, healthcare, and travel, could result in “incremental sales/margin pressure in 2024E,” the analyst wrote.

“We expect Weibo’s ad revenue to grow 3-4% yoy in 2024E or 3% CAGR in 2023-26E (cFX), with non-GAAP operating margin stepping down -2.4pp yoy in 2024E due to investments in vertical content and user growth,” he further stated.

WB Price Action: Shares of Weibo had declined by 1.79% to $9.33 at the time of publication on Thursday.

Image: Shutterstock

Latest Ratings for WB

Mar 2022UBSDowngradesBuyNeutral
Mar 2022BenchmarkMaintainsBuy
Mar 202286 ResearchUpgradesHoldBuy

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.